Dickkopf-1 reduces hypertrophic changes in human chondrocytes derived from bone marrow stem cells

Area of Science:

• * Stem Cell Biology
• * Tissue Engineering
• * Molecular Signaling

Background:

• * Mesenchymal stem cells (MSCs) differentiate into chondrocytes in vitro, but often develop a pre-apoptotic hypertrophic phenotype.
• * The WNT/β‑catenin pathway is active during chondrogenic differentiation and promotes hypertrophy.
• * Understanding genes regulating chondrocyte phenotype is crucial for cartilage tissue engineering.

Purpose of the Study:

• * To investigate the role of Dickkopf-1 (DKK1) in regulating chondrocyte differentiation and hypertrophy.
• * To determine if DKK1 can promote a stable, healthy chondrocyte phenotype for cartilage tissue engineering.

Main Methods:

• * RNA sequencing (RNA-seq) analysis of various tissue types to identify DKK1 expression.
• * Pellet cell culture system using bone marrow MSCs cultured in chondrogenic medium with two doses of DKK1 (50 and 200 ng/ml) for 21 days.
• * Analysis of β‑catenin expression, hypertrophy markers (COL10A1, ALPL), and healthy cartilage markers (COL2A1, GAGs).

Main Results:

• * DKK1 is expressed in cartilage tissue, suggesting its inhibitory role in WNT signaling.
• * Higher doses of DKK1 reduced β‑catenin expression and nuclear localization.
• * DKK1 treatment decreased the expression and activity of hypertrophy markers (COL10A1, ALPL).
• * DKK1 treatment increased the expression of healthy articular cartilage markers (COL2A1, GAGs).

Conclusions:

• * Exogenous DKK1 effectively impedes chondrocyte progression to a prehypertrophic stage by inhibiting the WNT/β‑catenin pathway.
• * DKK1 stimulates the expression of healthy articular cartilage markers, suggesting it promotes a mature chondrocyte phenotype.
• * DKK1 holds potential for advancing cartilage tissue engineering strategies for joint repair.